Artiva Biotherapeutics In...

7.06
0.53 (8.12%)
At close: Jan 21, 2025, 3:59 PM
7.07
0.14%
After-hours Jan 21, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -4.05 -3.61 -2.94 -11.73 n/a
PS Ratio 3.35 42.79 105.39 n/a n/a
PB Ratio -0.69 -1.5 -2.37 -9.78 n/a
P/FCF Ratio -2.21 -3.69 -12.39 -15.26 n/a
P/OCF Ratio -2.37 -4.15 -13.79 -15.58 n/a
OCF/S Ratio -1.42 -10.31 -7.64 n/a n/a
Debt / Equity Ratio -0.1 -0.14 -0.02 -0.1 n/a
Quick Ratio 6.53 4.08 8.41 4.53 n/a
Current Ratio 6.53 4.08 8.41 4.53 n/a
Asset Turnover 0.32 0.04 0.01 n/a n/a
Interest Coverage n/a n/a n/a -91.81 n/a
Return on Equity (ROE) 0.17 0.41 0.81 0.83 n/a
Return on Assets (ROA) -0.26 -0.44 -0.42 -0.62 n/a
Return on Capital (ROIC) -0.33 -0.56 -0.35 -0.78 n/a
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 100.00% 100.00% n/a n/a
Net Profit Margin -82.69% -1.18K% -3.59K% n/a n/a
Pretax Profit Margin -82.48% -1.18K% -3.59K% n/a n/a
Operating Profit Margin -91.58% -1.21K% -2.66K% n/a n/a
FCF Margin -151.34% -1.16K% -850.55% n/a n/a
EBITDA Margin -84.81% -1.19K% -3.58K% n/a n/a